Replies to post #40747 on Medizone Intl. (fka MZEIQ)

[Zeppo]

Thanks for your commentary, Jack. A lot more should be going on now than a decade ago. A seemingly flawless product has been built. Shareholders have something tangible to view. The inexperience of dealing with testing, marketing and regulatory issues is half the battle here. The other half of the battle is management and majority shareholder unwillingness to enact positive changes that would save thousands of lives and put dollars into the pockets of those same shareholders. Where's the logic? Maybe.....just maybe....some of the majority shareholders have scratched their collective heads enough times to realize that things aren't right. It's not all about the EPA. There's a whole planet out there, and a good portion of it doesn't care about the EPA. Other U.S. companies have proven that premise. Having a shareholder meeting might be in the cards anyway, because existing shares are dwindling down and PPLs are not the rage anymore.

[Eli's Gone]

All he has to do is get the board to issue preferred shares (which are already authorized) with super voting rights and common shareholders are stuck:

Our Board of Directors may authorize the issuance of preferred stock and designate rights and preferences that will dilute the ownership and voting interests of existing stockholders without their approval. Our Articles of Incorporation authorize us to issue preferred stock. The Board of Directors is authorized to designate, and to determine the rights and preferences of any series or class of preferred stock. The Board of Directors may, without stockholder approval, issue shares of preferred stock with dividend, liquidation, conversion, voting or other rights which are senior to the common stock or which could adversely affect the voting power or other rights of the existing holders of outstanding shares of preferred stock or common stock. Additionally, the issuance of preferred stock may have the effect of decreasing the market price of the common stock and reduce the likelihood that common stockholders will receive dividend payments and payments upon liquidation. The issuance of additional shares of preferred stock may also adversely affect an acquisition or change in control of the Company.